StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a research report released on Monday. The firm issued a hold rating on the stock.
China Pharma Price Performance
Shares of CPHI opened at $0.11 on Monday. China Pharma has a 1-year low of $0.08 and a 1-year high of $0.53. The stock has a market cap of $5.43 million, a PE ratio of -1.31 and a beta of 0.69. The firm has a 50-day simple moving average of $0.11 and a two-hundred day simple moving average of $0.16.
Get China Pharma alerts:About China Pharma
(Get Rating)
China Pharma Holdings, Inc engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products.Featured Stories
- Get a free copy of the StockNews.com research report on China Pharma (CPHI)
- Procter & Gamble Earnings: A Gamble Worth Taking
- Stocks Slide, Economic Report Paints Gloomy Picture For Economy
- What does Nu Holdings Stock Have To Do With Warren Buffett?
- J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
- Is Intel Stock On The Verge Of Breaking Out?
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.